2021年11月30日，“中欧生物健康合作月”中又一颇受中欧各方关注的活动——“中欧生物健康国际合作机遇宣介会”闪亮登场。活动吸引了中国与欧洲生物健康领域约300人线上参会。中欧生物健康合作网络、德国亥姆霍兹协会中国办事处、北京中关村科学城创新发展有限公司、中欧科研合作网相关负责人应邀出席了此次活动。
On Nov.30th, 2021 China-EU Health Cooperation Month, staged another highly anticipated event "Info-day of China-EU Health Collaboration Opportunities" among a series of webinars throughout November. Chief executives of various interested health stakeholders from both EU and China, including ZGC Science City Innovation Development Co.,Ltd, SENET, Helmholtz Society(China), EURAXESS have been invited to address the event.
“中欧生物健康合作月”活动由欧盟委员会生物医药处和北京市科协、中关村科学城管委会、国家卫健委卫生发展研究中心三家中方机构共同主办，北京中关村科学城创新发展有限公司、首都海智生物健康科委会执行秘书处、中欧生物健康合作网等中欧机构联合承办。11月以来，本次合作月已经召开了多次关于AI技术健康领域运用、流行病防治、精准医疗等议题的合作研讨与对话活动。
China-EU Cooperation Month is made up of a series of online events from Nov.3rd till Dec. 3rd. It was co-sponsored by the Heath Division of European Commission and on the Chinese side the Administration of Zhongguancun ( abbreviated as ZGC below) Science City, Beijing Association for Science and Technology and China National Health Development Research Center. Health stakeholders from China and EU have already discussed hot health topics, such as AI application in health industry, prevention and treatment of infectious diseases and precision diagnosis ( personalized medicine ) by far. These events have been warmly welcomed by the health communities of both sides.
宣介会上，来自中欧生物健康合作网络的Timo Strohäker 博士、德国亥姆霍兹协会中国办事处的何宏博士分别介绍了欧盟2021-2027国际科技合作计划“地平线欧洲”下中欧健康领域合作的项目招标、以及亥姆霍兹在华业务和中德科创合作机遇，中欧科研合作网络负责人则着重介绍了其对中欧科研人员交流往来提供的相关信息、合作伙伴搜寻等服务。
The info-day again attracted wide participation of around 300 interested health researchers, experts and startups. Dr Timo Strohäker with SENET and Dr Hehong with Helmholtz Society(China) respectively presented on the health calls for international cooperation under EU’s 2021-2027 Horizon Europe Program, and the business of Helmholtz Society in China as well as the China-Germany health collaborative opportunities. The representative with EURAXXES mainly introduced their services on the partner-searching and mobility for Chinese and European health communities.
北京中关村科学城创新发展有限公司副总经理戴廉向参会人员展示了中关村科学城生物健康产业的创新生态。她提出，基于中关村科学城基础研究资源得天独厚、高端科技智力资源密集等独特的创新要素，中关村科学城的生物健康产业呈现出原始创新、学科交叉、专精特新等典型特征；中关村科学城公司，则秉承“投资助力产业、服务成就创新”的价值理念，在中关村科学城的生物健康产业集群方面提供了包括投资、孵化、社群等全方位的创新生态化服务。
同时，她也向中欧合作伙伴表达了中关村科学城公司希望为中欧生物健康国际合作提供各种服务的真诚意愿。
Mrs DAI Lian, deputy general manager with ZGC Science City Innovation Development Co.,Ltd, introduced innovation ecosystem for health development in ZGC.She highlighted ZGC’s strengths in nurturing a robust health industry, including rich basic research resources and high concentration of STI talents. These innovation factors enable ZGC health industry to be innovative, multi-disciplinarily active and highly specialized. The company,in the spirit of investing for the industrial development and serving for innovation,would serve the development of a health cluster in ZGC with capital, incubating services and other services that encompassing different stages of health ecosystem.She sincerely welcomed interested Chinese and European health researchers, experts and startups to find their home in ZGC Science City with the service of the company.
与会各方对与中关村科学城在生物健康领域的合作机遇表达了浓厚的兴趣，也对中关村科学城公司重点搭建的水木东方医用机器人创新中心、巢生生物医药实验室、百放英库新药发现平台等专业服务平台，以及贯穿企业成长全周期的投资基金等科创服务予以了高度的评价。
The participants of the event have shown the strong interests in the health collaborative opportunities with ZGC Science City, also highly commented on the professional health service platform supported by the company, such as the Beijing Medical Robotics Industry Innovation Center, Boston-Beijing Nest.Bio Biomedical Innovation Incubator, and Biofront Therapeutics(Beijing),etc as well as the health life-cycle funds the company set.
京公网安备 11010802035251号